Human Mesenchymal Stem Cells
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Human Mesenchymal Stem Cells, covering 2013-05-31 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease. [Phase 2]